Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?
- DOI
- 10.1016/j.hemonc.2019.12.003
- Published
- 2020-04
- Container
- Hematology/Oncology and Stem Cell Therapy
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.hemonc.2019.12.003,
title = {Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?},
author = {Lisa V.E. Oostenbrink and Cornelia M. Jol-van der Zijde and Anja M. Jansen-Hoogendijk and Emma S. Pool and Astrid G.S. van Halteren and Dirk Jan A.R. Moes and Robbert G.M. Bredius and Alex B. Mohseny and Frans J.W. Smiers and Maarten J.D. van Tol and Marco W. Schilham and Arjan C. Lankester},
year = {2020},
journal = {Hematology/Oncology and Stem Cell Therapy},
doi = {10.1016/j.hemonc.2019.12.003},
url = {https://doi.org/10.1016/j.hemonc.2019.12.003}
}RIS
TY - JOUR TI - Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation? AU - Lisa V.E. Oostenbrink AU - Cornelia M. Jol-van der Zijde AU - Anja M. Jansen-Hoogendijk AU - Emma S. Pool AU - Astrid G.S. van Halteren AU - Dirk Jan A.R. Moes AU - Robbert G.M. Bredius AU - Alex B. Mohseny AU - Frans J.W. Smiers AU - Maarten J.D. van Tol AU - Marco W. Schilham AU - Arjan C. Lankester PY - 2020 JO - Hematology/Oncology and Stem Cell Therapy DO - 10.1016/j.hemonc.2019.12.003 UR - https://doi.org/10.1016/j.hemonc.2019.12.003 ER -
APA
Oostenbrink, L. V., Zijde, C. M. J. D., Jansen-Hoogendijk, A. M., Pool, E. S., Halteren, A. G. V., Moes, D. J. A., Bredius, R. G., Mohseny, A. B., Smiers, F. J., Tol, M. J. V., Schilham, M. W., & Lankester, A. C. (2020). Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?. Hematology/Oncology and Stem Cell Therapy. https://doi.org/10.1016/j.hemonc.2019.12.003
Source records
- crossref · retrieved 2026-09-26T13:09:03.035Z